BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 9620286)

  • 1. Distinct circadian time structures characterize myeloid and erythroid progenitor and multipotential cell clonogenicity as well as marrow precursor proliferation dynamics.
    Wood PA; Hrushesky WJ; Klevecz R
    Exp Hematol; 1998 Jun; 26(6):523-33. PubMed ID: 9620286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling pathways implicated in hematopoietic progenitor cell proliferation and differentiation.
    Bugarski D; Krstic A; Mojsilovic S; Vlaski M; Petakov M; Jovcic G; Stojanovic N; Milenkovic P
    Exp Biol Med (Maywood); 2007 Jan; 232(1):156-63. PubMed ID: 17202596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian variations in mouse bone marrow.
    Aardal NP; Laerum OD
    Exp Hematol; 1983 Oct; 11(9):792-801. PubMed ID: 6641825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
    Scheding S; Media JE; Nakeff A
    Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
    Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
    Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCL expression at critical points in human hematopoietic lineage commitment.
    Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
    Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparate regulation of human fetal erythropoiesis by the microenvironments of the liver and bone marrow.
    Muench MO; Namikawa R
    Blood Cells Mol Dis; 2001; 27(2):377-90. PubMed ID: 11259159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colony formation in agar by adult bone marrow multipotential hemopoietic cells.
    Johnson GR
    J Cell Physiol; 1980 Jun; 103(3):371-83. PubMed ID: 7400223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of hematopoietic progenitor cells towards the myeloid and B-lymphoid lineage by hepatocyte growth factor (HGF) and thrombopoietin (TPO) together with early acting cytokines.
    Grassinger J; Mueller G; Zaiss M; Kunz-Schughart LA; Andreesen R; Hennemann B
    Eur J Haematol; 2006 Aug; 77(2):134-44. PubMed ID: 16856909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian and seasonal rhythms in murine bone marrow colony-forming cells affect tolerance for the anticancer agent 4'-O-tetrahydropyranyladriamycin (THP).
    Lévi F; Blazsek I; Ferlé-Vidovic A
    Exp Hematol; 1988 Sep; 16(8):696-701. PubMed ID: 3402557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Special Education.
    Kozutsumi H
    Oncologist; 1996; 1(1 & 2):116-118. PubMed ID: 10387976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronobiology in hematology and immunology.
    Haus E; Lakatua DJ; Swoyer J; Sackett-Lundeen L
    Am J Anat; 1983 Dec; 168(4):467-517. PubMed ID: 6364772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal.
    van Os R; Robinson S; Sheridan T; Mauch PM
    Stem Cells; 2000; 18(2):120-7. PubMed ID: 10742384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhythms in human bone marrow and blood cells.
    Smaaland R; Sothern RB; Laerum OD; Abrahamsen JF
    Chronobiol Int; 2002 Jan; 19(1):101-27. PubMed ID: 11962670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Qa-m7 antigen expression is characteristic of primitive hemopoietic progenitors in regenerating marrow.
    Bertoncello I; Bartelmez SH; Bradley TR; Hodgson GS
    J Immunol; 1987 Aug; 139(4):1096-103. PubMed ID: 3611787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of the in vitro effects of testosterone and erythropoietin on Cfu-E and Bfu-E proliferation by pretreatment of the donor rats with cyproterone and flutamide.
    Malgor LA; Valsecia M; Vergés E; De Markowsky EE
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(2):99-105. PubMed ID: 9695882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of early murine hemopoietic progenitor cell proliferation after in vivo locoregional administration of transforming growth factor-beta 1.
    Goey H; Keller JR; Back T; Longo DL; Ruscetti FW; Wiltrout RH
    J Immunol; 1989 Aug; 143(3):877-80. PubMed ID: 2745976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy between erythropoietin and stem cell factor during erythropoiesis can be quantitatively described without co-signaling effects.
    Wang W; Horner DN; Chen WL; Zandstra PW; Audet J
    Biotechnol Bioeng; 2008 Apr; 99(5):1261-72. PubMed ID: 17969148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.